Fuhui Venture Capital
Overview
Fuhui Venture Capital is a venture capital firm that focuses on technology transfer and early-stage investments in the healthcare, TMT, and advanced manufacturing sectors.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| DeepRoute.ai | Sep 2021 | Series B | - |
| Lindmik Pharmaceutical (Suzhou) Co., Ltd. | Jun 2024 | Early Funding | Co-investor |
| Chengdu Sicoresemi Semiconductor Co., Ltd. | Aug 2021 | Series B Extension | Co-investor |
| Leman Biotech | Jun 2024 | Angel | Co-investor |
| Hexaell Biotech Co., Ltd. | Apr 2026 | Series B++ | Co-investor |
For institutional investors. Book with your work email.
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
Where is Fuhui Venture Capital based?
Fuhui Venture Capital is headquartered in Beijing, Beijing, China.
When was Fuhui Venture Capital founded?
Fuhui Venture Capital was founded in 2008.
How many portfolio companies does Fuhui Venture Capital have?
Fuhui Venture Capital has 6 portfolio companies in Caplight's dataset.
What are some companies in Fuhui Venture Capital's portfolio?
Portfolio companies visible on Caplight include DeepRoute.ai, Lindmik Pharmaceutical (Suzhou) Co., Ltd., Chengdu Sicoresemi Semiconductor Co., Ltd., Leman Biotech, Hexaell Biotech Co., Ltd..
What was Fuhui Venture Capital's most recent investment shown here?
Fuhui Venture Capital's most recent investment in this portfolio sample was in Hexaell Biotech Co., Ltd. in 2026.
What sectors does Fuhui Venture Capital focus on?
Fuhui Venture Capital focuses on Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Mobility, Transportation & Logistics, Telecommunications & Networking, Frontier & Industrial Tech, AI, Data & Cloud Infrastructure.
What company stages does Fuhui Venture Capital focus on?
Fuhui Venture Capital typically invests at the MultiStage stage.
What is Fuhui Venture Capital's AUM?
Fuhui Venture Capital's assets under management are estimated between $100.0M and $250.0M.